CROs/Service Providers

Veristat acquires UK-based CRO Spero Oncology

Monday, May 2, 2016

Veristat, a full service CRO, is expanding its clinical research offerings into Europe through the acquisition of U.K.-based CRO Spero Oncology. Spero Oncology specializes in providing clinical operations support for oncology clinical trials primarily throughout Europe, but also in Australia and New Zealand. With the acquisition of Spero Oncology, Veristat now offers its clients full clinical operations support in Europe including feasibility studies, legal representation in the European Union, clinical monitoring, project management, protocol writing and regulatory strategy.

[Read More]

Interventional Concepts, ACRES ink alliance for Colombia

Friday, April 29, 2016

Interventional Concepts, a CRO for innovative pharma, biotech and medtech development-stage companies proposing to conduct clinical trials in Colombia, and the Alliance for Clinical Research Excellence and Safety (ACRES), a multi-sector nonprofit operating in the public interest and committed to transforming the global clinical research environment, have announced a strategic alliance, joining Interventional Concepts with current ACRES Allies in their efforts to build ACRES’ shared global clinical research system.

[Read More]

WCCT Global opens offices in Seoul, South Korea

Friday, April 29, 2016

WCCT Global, a full-service CRO, is announcing the opening of an office and clinical operations in Seoul, Korea. With the expansion of operations into South Korea, the company is poised to further establish itself as a global CRO. The expansion is a part of the company’s efforts to increase its capacity for conducting high quality clinical research in one of Asia’s fastest-growing countries for biopharmaceutical development.

[Read More]

Medrio, Clinartis partner

Thursday, April 21, 2016

Medrio, a Software as a Service (SaaS) company providing cloud-based data management capabilities to clinical researchers, and Clinartis, a CRO providing clinical trial services in the U.S. and Europe, have announced a new partnership under Medrio’s Partner Program. Clinartis and Medrio have cultivated a business relationship through numerous phase I studies for which the CRO has utilized Medrio’s flagship phase I-focused product, m1.

[Read More]

Snapdragon Chemistry expands to new labs in Cambridge, MA

Tuesday, April 5, 2016

Snapdragon Chemistry has moved to new lab facilities in Cambridge, Massachusetts. Snapdragon’s corporate partner, Zaiput Flow Technologies, has also moved to the 85 Bolton Street site. This co-location will enhance the collaboration of these strategic partners and accelerate the development of advanced continuous chemical manufacturing technologies and solutions.

[Read More]